Clobetasol Propionate

Overview

Clobetasol Propionate is a synthetic corticosteroid used primarily in dermatology to reduce inflammation and itching associated with various skin conditions. It is highly potent and is often prescribed for short-term use only due to potential systemic side effects.

API suppliers (14)

Suppliers of Clobetasol Propionate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• FARMABIOS SPA1 active DMF
• FARMABIOS SPA1 active DMF
• TAPI NL BV1 active DMF
• HALCYON LABS PRIVATE LTDIndia1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• TAPI NL BV1 active DMF
• FARMABIOS SPA1 active DMF
• SYMBIOTEC PHARMALAB PRIVATE LTD1 active DMF
• SYMBIOTEC PHARMALAB PRIVATE LTD1 active DMF
• SYMBIOTICA SPECIALITY INGREDIENTS SDN BHDMalaysia1 active DMF
• CESQUISA SA
• GlaxoSmithKline plcUnited Kingdom
• MAHIMA LIFE SCIENCES PRIVATE LTD
• Taro Pharmaceutical Industries Ltd.Israel

Patent & exclusivity (US)

Per the FDA Orange Book (58 approved US products), the latest listed US patent on Clobetasol Propionate expires 8 May 2036 and exclusivity 4 Mar 2027. Generic API sourcing typically opens up once these lapse.

Therapeutic areas